BELVIQ XR (Eisai Inc.)
Welcome to the PulseAid listing for the BELVIQ XR drug offered from Eisai Inc.. This Serotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eisai Inc. |
NON-PROPRIETARY NAME: | lorcaserin hydrochloride hemihydrate |
SUBSTANCE NAME: | LORCASERIN HYDROCHLORIDE HEMIHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-07-15 |
END MARKETING DATE: | 0000-00-00 |
BELVIQ XR HUMAN PRESCRIPTION DRUG Details:
Item Description | BELVIQ XR from Eisai Inc. |
LABELER NAME: | Eisai Inc. |
DEA SCHEDULE: | CIV
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2016-07-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62856-535_5bb86799-5f33-47e6-9209-3cc5963bfa58 |
PRODUCT NDC: | 62856-535 |
APPLICATION NUMBER: | NDA208524 |
Other LORCASERIN HYDROCHLORIDE HEMIHYDRATE Pharmaceutical Manufacturers / Labelers: